Chemopreventive Agent Development

Designs, develops, implements, and monitors research on interventions that may block, reverse, or delay the early stages of cancer. Investigates nutrients, micronutrients, natural products, pharmacologic agents, biomolecules, and vaccines from preclinical to early-phase I clinical studies. Helps investigators to bridge the gaps between biology and identifying potential targets, and between discovery of targets and agents and clinical testing in people.

Major Programs

Staff List

Grid View

Name, Email, Phone	Room	Group(s)/Office
Asefa, Wosene wosene.asefa@nih.gov 240-276-6422	5E504	Program Support Assistant \| Chemopreventive Agent Development
Biswas, Kajal, Ph.D. kajal.biswas2@nih.gov 240-276-5614	5E540	Program Officer \| Chemopreventive Agent Development
Cholewa, Brian, Ph.D. brian.cholewa@nih.gov 240-276-7545	5E446	Deputy Chief \| Chemopreventive Agent Development
Clifford, John, Ph.D. john.clifford@nih.gov 202-235-4482	5E430	Program Officer \| Chemopreventive Agent Development
Gunasekharan, Vignesh, Ph.D. vignesh.gunasekharan@nih.gov 240-276-5814	5E438	Program Officer \| Chemopreventive Agent Development
Mohammed, Altaf, Ph.D. altaf.mohammed@nih.gov 240-276-6082	5E542	Deputy Chief \| Chemopreventive Agent Development
Nalli, Ancy, Ph.D., M.S. ancy.nalli@nih.gov 202-276-5265	5E536	Program Officer \| Chemopreventive Agent Development
Sei, Shizuko, M.D. shizuko.sei@nih.gov 240-276-5005	5E452	Co-Chief \| Chemopreventive Agent Development
Shoemaker, Robert, Ph.D. robert.shoemaker@nih.gov 240-276-7077	5E454	Co-Chief \| Chemopreventive Agent Development Acting Chief \| Nutritional Science
Vlad, Anda, M.D., Ph.D. anda.vlad@nih.gov 240-276-6422	5E538	Program Officer \| Chemopreventive Agent Development

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Elmore, Joann G	University Of California Los Angeles United States	Optimizing the Human-Computer Interaction in Pathology: Understanding the Impact of Computer-Aided Diagnosis Tools on Pathologists' Interpretive Performance	1R01CA288824-01A1	Claire Zhu, Ph.D.
Elswick, Ronald K	Virginia Commonwealth University United States	A Randomized Controlled Trial using a Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults with Cancer	5R01CA286799-03	Asad Umar, D.V.M., Ph.D.
Esserman, Laura J	University Of California, San Francisco United States	Extending the Diversity, Reach, and Generalizability of the WISDOM Study	5R01CA237533-05	Claire Zhu, Ph.D.
Esserman, Laura J	University Of California, San Francisco United States	WISDOM: A platform to optimize subtype-specific screening and prevention	5P01CA281826-02	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Fabian, Carol J.	University Of Kansas Medical Center United States	Biomarker-Based Phase IIB Trial of (Bazedoxifene-Conjugated Estrogen) to Reduce Risk for Breast Cancer	5R01CA249437-05	Edward Sauter, M.D., Ph.D.
Fahrmann, Johannes F	University Of Tx Md Anderson Can Ctr United States	Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer	5U01CA282216-03	Claire Zhu, Ph.D.
Faller, Bryan	Decatur Memorial Hospital United States	Heartland Cancer Research NCORP	3UG1CA189830-11S1	Vanessa A. White, M.P.H.
Farrar, Christian T	Massachusetts General Hospital United States	Novel metabolomic contrast probes for human lung cancer characterization	4R01CA273010-04	Guillermo Marquez, Ph.D.
Feng, Ziding	Fred Hutchinson Cancer Center United States	Consortium on Translational Research in Early Detection of Liver Cancer:Data Management and Coordinating Center (DMCC)	5U24CA230144-09	Guillermo Marquez, Ph.D.
Fiol, Guilherme Del	University Of Utah United States	GARDE: Scalable Clinical Decision Support for Individualized Cancer Risk Management	5U24CA274582-03	Christos Patriotis, Ph.D., M.Sc.
Fitzgibbon, Marian L.	University Of Illinois At Chicago United States	Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer Risk	5R01CA250390-05	Young Kim, Ph.D.
Flory, James H	Sloan-Kettering Inst Can Research United States	Managing metabolic disruption in pancreatic cancer to prevent weight loss and improve quality of life	5R21CA277464-02	Gabriela Riscuta, M.D., CNS
Flowers, Lisa C.	Emory University United States	Screening Strategies Among High-Risk Populations for Anal Cancer	5R01CA285198-03	Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Flowers, Lisa C.	Emory University United States	Georgia Consortium to Eliminate Cervical Cancer in Women Living with HIV (GaCECC-WLWH)	5UG1CA284884-03	Maria Silvina Frech, Ph.D., M.S.
Flynn, Kathryn E	Medical College Of Wisconsin United States	Symptom Monitoring using Patient-Reported Outcomes to Optimize Medication Use (SyMPTOM)	5R01CA285925-02	Brandy Heckman-Stoddard, Ph.D., M.P.H.

Chemopreventive Agent Development

On This Page

Major Programs

Staff List

Grants